About Mead Johnson Nutrition
Mead Johnson Nutrition’s (MJN) product portfolio addresses a broad range of nutritional needs for infants, children, and expecting and nursing mothers. The company’s product portfolio consists of two principal product categories: infant formula and children’s nutrition. These product categories can be separated into the following five general product types:
- Routine infant, for healthy consumers, which includes Enfamil Premium, Enfapro Premium, Enfamil A+ and Enfalac A+
- Solutions for infants with mild to severe nutritional needs, which includes Enfamil Gentlease and Enfamil AR
- Specialty products, for infants with mild to severe nutritional needs, which includes Enfamil Premature and EnfaCare
- Children’s nutrition, for children at different stages of development, which includes Enfagrow, Sustagen, and Lactum.
- Other products, which includes vitamins and supplements, Expecta, EnfaMama, and Enfamil Poly-Vi-Sol
Mead Johnson’s category revenue contributions
Infant formula, including a routine infant, solutions, and specialty, accounted for 57% of the total revenue in fiscal 2014, which for Mead Johnson ended on December 31, 2014. By comparison, children’s nutrition accounted for another 41% of Mead Johnson’s total revenues over the same period.
The Enfa family of brands, including Enfamil infant formula, is the world’s leading brand franchise in pediatric nutrition, based on retail sales, and accounted for approximately 80% of total Mead Johnson’s sales for fiscal 2014.
Peer group comparison
Mead Johnson’s competitor in the infant and child nutrition business (XLP) Nestlé (NSRGY) generated 15.9% of its total sales from its nutrition and health science segment in fiscal 2014. By comparison, pediatric nutrition accounted for 19.2% of Abbott Laboratories’ (ABT) fiscal 2014 revenue, whereas Kraft Heinz Foods Company (KHC) generated 4% or $1.2 billion of its total pro forma fiscal 2014 revenue from infant nutrition business. Infant nutrition accounts for approximately 20% of the Danone’s revenues.
Fiscal 2014 ended on December 31, 2014, for all these peer group companies of Mead Johnson. MJN has a weight of 0.09% in the iShares Russell 1000 Growth ETF (IWF), a growth-oriented ETF. Now let’s continue to the next part for a breakdown of Mead Johnson’s segments.
Now let’s continue to the next part for a breakdown of Mead Johnson’s segments.